3KQ-24409-42843
3 vaccinations
0 coded responses
1 check-in
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 971 / OR
- Registered
- 2022-02-26
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-19
Dose 1 — Pfizer-BioNTech
-
2021-05-04
Dose 2 — Pfizer-BioNTech
-
2022-02-26
Registered in v-safe
-
2022-02-26
Dose 3 — Pfizer-BioNTech
-
2022-02-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2022-02-28
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-19 | Pfizer-BioNTech | No |
| 2 | 2021-05-04 | Pfizer-BioNTech | No |
| 3 | 2022-02-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-28 | Unsuccessful |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.